23 July 1999
Consolidation in the UK pharmaceutical industry has forced the top three companies to review their property strategies, putting new emphasis on flexibility. Lucy Benyon looks at the challenges posed to the traditional property world by this industry
You must be logged in to view premium stories.
Take out a print and online or online only subscription and you will get immediate access to:
To get access to premium content subscribe today
Alternatively REGISTER for a free trial to access up to 4 articles and sign up for email alerts